جستجوی استاد راهنمای دانشگاهی

Matthias Mannمشاهده پروفایل

استاد

• Mass Spectrometry
• Proteomics
• Systems Biology
• +۶ مورد دیگر

Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.

• Proteasome Research
• Structural Biology
• Enzyme Mechanisms
• +۲ مورد دیگر

Michael Groll serves as Professor and Chair of Biochemistry at the Technical University of Munich (TUM), where he leads structural biology and enzymology research with a focus on proteasome mechanisms and inhibitor development. His laboratory, located at the Ernst-Otto-Fischer-Str. 8 campus in Garching, maintains active collaborations in drug discovery for cancer and infectious diseases. His primary research domains include proteasome inhibition, enzyme catalysis, and natural product biosynthesis, employing X-ray crystallography, biochemical assays, and bioengineering to dissect molecular mechanisms. Recent work emphasizes AI-guided enzyme optimization, bacterial stress response targeting, and structural characterization of halogenation enzymes, reflecting interdisciplinary approaches bridging chemistry and biology. Analysis of his 2023-2025 publications reveals consistent innovation in proteasome-targeted therapeutics, with 15 high-impact papers featuring structural insights into enzyme-inhibitor complexes and biosynthetic pathways. Key trends include engineering megasynthetases for immunoproteasome inhibitors, optical control of protein degradation, and elucidating metal-dependent mechanisms in antibiotic biosynthesis. No scientific awards were documented in the provided source material. While specific grant details and student mentorship records were not disclosed, his extensive publication record indicates leadership in collaborative research projects involving structural biology and chemical biology methodologies. The Chair of Biochemistry under Prof. Groll operates as a hub for structural enzymology, housing facilities for protein crystallography, enzyme kinetics, and natural product characterization. His team actively contributes to TUM's research ecosystem through partnerships with pharmaceutical groups and international structural biology consortia.

• Intensive Care Medicine
• Critical Care
• Sepsis
• +۹ مورد دیگر

Stefan Kluge is a Professor at the Department of Intensive Care within the University Medical Center Hamburg-Eppendorf . With over 150 publications in 2025-2024 alone, his work focuses on critical care medicine, sepsis, ARDS, and cardiogenic shock. His recent research explores ARDS impact on liver cirrhosis outcomes Hyperoxia effects in traumatic brain injury Biomarkers for cardiogenic shock prognosis Novel retrograde limb perfusion techniques during ECPR Dual-energy CT for body composition analysis He contributes extensively to German national guidelines for nosocomial pneumonia and participates in multi-center critical care trials. Stefan Kluge's collaborations span neuro-intensive care , cardiovascular research , and infection/immunity domains. His work integrates machine learning applications and medical informatics to improve ICU decision-making.

• Oral Surgery
• Maxillofacial Surgery
• Head and Neck Cancer
• +۱۲ مورد دیگر

Martin Gosau is a Professor at the Clinic and Polyclinic for Oral and Maxillofacial Surgery within the Medical Faculty of the University Medical Center Hamburg-Eppendorf (UKE). His research focuses on Oral Surgery , Maxillofacial Surgery , and Regenerative Medicine , with a strong emphasis on Dental Implants , Head and Neck Cancer , and Oral Pathology . University: University Medical Center Hamburg-Eppendorf School: Medical Faculty Department: Oral and Maxillofacial Surgery Academic Rank: Professor His recent work explores: Oral Health in Genetic Disorders (e.g., hypophosphatasia) Advanced Surgical Techniques (e.g., nanosecond lasers, fluorescence angiography) Biomaterials and Tissue Engineering (e.g., silk fibroin membranes, extracellular vesicles) Cancer Prognostics (e.g., DCBLD1 overexpression in HNSCC) Key trends in his 15 most recent articles include applications of machine learning in oral diagnostics, stem cell research for bone regeneration, and biomaterials in reconstructive surgery. He frequently collaborates with Ralf Smeets and Thomas Vollkommer , with publications spanning Frontiers in Immunology , Oral Surgery , and Scientific Reports .

Franz Lennard Ricklefsمشاهده پروفایل

استاد

• Neurosurgery
• Neuro-oncology
• Molecular Neurobiology
• +۵ مورد دیگر

Prof. Dr. med. Franz Lennard Ricklefs is a Senior Physician and Head of the Working Group at the Department of Neurosurgery, University of Hamburg Faculty of Medicine. He is a Medical Specialist in Neurosurgery with cross-disciplinary expertise in neuro-oncology, molecular pathology, and extracellular vesicle research. Affiliations: University Medical Center Hamburg-Eppendorf (UKE), European Liquid Biopsy Society (ELBS), International Consortium on Meningiomas (ICOM) Research Interests: His work focuses on neurosurgical oncology, particularly glioblastoma and meningioma pathobiology. He investigates DNA methylation patterns, extracellular vesicle biomarkers, and liquid biopsy implementation in clinical neuro-oncology. Additional interests include surgical outcomes for epilepsy and aneurysm management. Article Trends: Over the last decade, Dr. Ricklefs has published extensively on: Extracellular vesicle applications as liquid biopsy markers DNA methylation subclasses for glioblastoma and meningioma Multicenter surgical outcome benchmarking Immune evasion mechanisms in neuro-oncology Technological innovations in neurosurgical visualization Molecular characterization of rare CNS tumors Professional Contributions: He co-authored the MISEV2023 guidelines for extracellular vesicle studies and participates in international consensus reviews for meningioma classification. His collaborations span institutions across Europe and North America.

Thomas Koopمشاهده پروفایل

استاد

• Atmospheric Chemistry
• Physical Chemistry
• Ice Nucleation
• +۴ مورد دیگر

Prof. Dr. Thomas Koop is a Professor of Physical Chemistry at Bielefeld University, where he leads the Atmospheric and Physical Chemistry research group within the Faculty of Chemistry. He has served as Dean of the Faculty of Chemistry from 2022-2024 and currently serves as Vice Dean (2024-2025). His research focuses on phase transition phenomena, particularly ice nucleation and growth, supercooled liquids, and the formation of amorphous glassy materials. His work has significant implications for understanding atmospheric aerosols, cloud formation mechanisms, and cryobiological processes. The group employs experimental techniques such as differential scanning calorimetry and optical cryo-microscopy, developing specialized equipment for studying phase transitions at micro and nanoscales. Prof. Koop's publication record shows a consistent focus on atmospheric chemistry with increasing exploration of biological ice nucleators, planetary atmospheres (including Venus), and the physical properties of atmospheric aerosols. His most cited work includes 'Water activity as the determinant for homogeneous ice nucleation in aqueous solutions' (Nature, 2000), which established fundamental principles in the field. 2024-2025: Vice Dean of Faculty of Chemistry 2022-2024: Dean of Faculty of Chemistry 2001-2022: Co-founder and Executive Editor of Atmospheric Chemistry and Physics Since 2004: Coordinator of Graduate School of Chemistry and Biochemistry Prof. Koop has mentored numerous students and postdoctoral researchers, contributing significantly to the development of the next generation of atmospheric scientists. His research has been supported by various funding agencies and has led to collaborations with institutions worldwide, from MIT and UC Berkeley to research centers in Switzerland and Israel.

Stephan A. Sieberمشاهده پروفایل

استاد

• Bioorganic Chemistry
• Antibiotic Development
• Chemical Proteomics
• +۵ مورد دیگر

Professor Stephan A. Sieber is a leading researcher in bioorganic chemistry at the Technical University of Munich (TUM), where he holds the Chair of Organic Chemistry II within the TUM School of Natural Sciences. His research program focuses on developing new drugs against multidrug-resistant bacteria through a multi-disciplinary approach that integrates synthetic chemistry, functional proteomics, microbiology, and protein biochemistry. His laboratory has made significant contributions to identifying unprecedented antibacterial targets beyond the scope of current antibiotics and exploiting these for chemical manipulation. Recent work has increasingly incorporated machine learning approaches to accelerate antibiotic discovery, with notable publications on AI-guided pipelines, drug-target interaction prediction, and high-throughput screening optimization. Sieber's research has resulted in the discovery of new active substances, some of which are currently being optimized for medical applications. His group's publications reveal a strong focus on chemical proteome mining, natural product mode of action studies, and novel antibacterial target identification. The lab has published extensively in top journals including Nature Chemistry, Nature Communications, and ACS Central Science. Inhoffen Medal (2024) Max Bergmann Medal (2023) ERC Advanced Grant (2023) Merck Future Insight Prize (2020) Klaus Grohe Prize (2020) ERC Consolidator Grant (2016) Professor Sieber leads an active research group that maintains a strong presence in the scientific community through regular publications, conference presentations, and collaborations. His laboratory website and BlueSky presence (@sieberlab.bsky.social) demonstrate ongoing research activities and engagement with the broader scientific community. He has successfully secured significant research funding including multiple ERC grants that have supported his innovative work in antibiotic discovery.

Mikhail Gelfandمشاهده پروفایل

استاد

• molecular evolution
• comparative genomics
• systems biology
• +۷ مورد دیگر

Mikhail Gelfand is a Full Professor and Director of the Center for Molecular and Cellular Biology at Skolkovo Institute of Science and Technology (Skoltech), where he also serves as Vice President for Biomedical Research. His distinguished career spans multiple prestigious institutions including Lomonosov Moscow State University and the Higher School of Economics. His educational background includes: 1985: MSc in mathematics (functional analysis) 1993: PhD in physics-mathematics (biophysics) 1998: DSc in biology (molecular biology) 2007: full professor (bioinformatics) Professor Gelfand's research focuses on molecular evolution, comparative genomics, systems biology, and metagenomics. His work examines eukaryotic processes including alternative splicing, mRNA editing, and chromatin structure, as well as bacterial genome evolution and transcription regulation. His lab combines data on three-dimensional chromatin structure, epigenetic states, and gene expression to obtain an integrated view of genome functioning across diverse organisms from humans to amoebae. One major research direction focuses on the evolution of transcript splicing and editing, while comparative analysis of bacterial genomes yields functional annotations of novel enzymes, transporters, and transcription factors. His recent publications demonstrate a strong focus on RNA editing in cephalopods, bacterial genome analysis, and computational approaches to understanding chromatin structure. The work spans molecular biology, evolutionary biology, and bioinformatics, with particular emphasis on how RNA editing contributes to adaptation and molecular evolution across metazoans. His research shows how edited adenines are more frequently substituted with guanine in evolution than their unedited counterparts, suggesting RNA editing may enhance adaptation. His notable awards include: The President of Russian Federation's Award for Young Doctors of Science (2000) The "Best Scientist of the Russian Academy of Sciences" award (2004) A. A. Baev Prize in Genomics and Genoinformatics (2007) Member of Academia Europaea (2010) As Director of the Center for Molecular and Cellular Biology, Professor Gelfand leads a research group that combines computational and experimental approaches to study genome function and evolution. His lab's work has significant implications for understanding molecular mechanisms of evolution and adaptation across diverse biological systems, from bacteria to complex eukaryotes. His research on metagenomics extends to practical applications in areas including coral disease, aphids, and oil wells.

Charlotte Kloftمشاهده پروفایل

استاد

• Pharmacometrics
• Computational Disease Modeling
• Therapeutic Drug Monitoring
• +۶ مورد دیگر

Professor Charlotte Kloft is Head of the Department of Clinical Pharmacy & Biochemistry at the Institute of Pharmacy, Free University of Berlin since 2011, and spokesperson for the interdisciplinary Graduate Research Training Program PharMetrX 'Pharmacometrics and Computational Disease Modelling' since 2008. She previously served as Professor and Head of the Department of Clinical Pharmacy at Martin-Luther-University Halle-Wittenberg (2005-2011) and as Scientific Assistant/Senior Assistant at Freie Universität Berlin (1999-2005). Her academic credentials include a habilitation in Clinical Pharmacy from Freie Universität Berlin (2003) and a Dr. rer. nat. (summa cum laude) from the same institution (1997). She earned her license as a pharmacist in 1992 after completing pharmacy studies at Johannes Gutenberg-University, Mainz (1987-1991). Professor Kloft's research focuses on pharmacometrics, computational disease modeling, and therapeutic drug monitoring across multiple therapeutic areas. Her work bridges pharmaceutical sciences with clinical practice, with particular emphasis on personalized dosing strategies for oncology, antimicrobial resistance, and inflammatory bowel diseases. She has pioneered research in optimizing drug dosing through pharmacokinetic/pharmacodynamic modeling, with applications in both antibiotic and cancer therapies. Her recent publications demonstrate a strong evolution toward integrating advanced computational approaches with clinical pharmacology, including machine learning applications in pharmacometrics, personalized dosing strategies for biologics during pregnancy, and developing nationwide infrastructure for therapeutic drug monitoring in cancer therapy through the ON-TARGET study. Academic Center of Excellence of Pharsight (now Certara), USA (since 2000) Habilitationsreisestipendium of Dr. August and Dr. Anni Lesmüller-Stiftung (2002) Ernst-Reuter-Preis of Ernst-Reuter-Gesellschaft (1998) Joachim-Tiburtius-Preis of Berlin Senate (1998) Young Investigator Award of EORTC-PAMM (1997) Professor Kloft has successfully supervised numerous doctoral students whose research spans diverse areas including CAR-T cell therapy, antimicrobial resistance, inflammatory bowel disease treatment optimization, and pharmacokinetic modeling of novel therapeutic agents. Her research group has secured significant funding for projects including GlobalResist, ON-TARGET, ABIMMUNE, COMBINATORIALS, and TAIN. She leads a vibrant research ecosystem at the Free University of Berlin with strong collaborations across Europe and internationally, maintaining state-of-the-art laboratory facilities including Biosafety Level 2 certified labs for infectious disease research.

• Organic Chemistry
• Photoredox Catalysis
• Electrochemistry
• +۶ مورد دیگر

Magnus A. Rueping is a highly distinguished Professor of Chemistry at King Abdullah University of Science and Technology (KAUST) in Thuwal, Saudi Arabia. With an impressive h-index of 107 and over 35,502 citations from 430 documents, he stands as a leading figure in modern synthetic chemistry. His research group maintains active collaborations with 651 co-authors worldwide, reflecting his significant impact on the chemical sciences community. Professor Rueping's research spans multiple cutting-edge areas in organic chemistry and catalysis. His work primarily focuses on developing novel sustainable methodologies including photoredox catalysis, electrochemical synthesis, and mechanochemistry. He has made significant contributions to the fields of $$\text{C-H}$$ functionalization, late-stage modification of complex molecules, and sustainable chemical transformations. His research group explores the intersection of traditional organic synthesis with emerging technologies to create more efficient and environmentally friendly chemical processes, with particular emphasis on nickel catalysis and metal-organic frameworks. Analysis of Professor Rueping's recent publications (2023-2025) reveals a strong trend toward integrating multiple activation modes in single catalytic systems. His work increasingly combines photochemistry, electrochemistry, and mechanochemistry (particularly resonant acoustic mixing) to develop novel catalytic platforms that minimize waste and energy consumption. A notable research direction involves the application of copper nanoclusters and cerium-based metal-organic frameworks as heterogeneous photocatalysts for challenging organic transformations. His group has also pioneered methods for $$\text{C-Ge}$$ and $$\text{C-S}$$ bond formation with exceptional selectivity. Professor Rueping's research has attracted substantial funding and recognition, as evidenced by his high citation metrics and publication record in top-tier journals including Nature Communications, Journal of the American Chemical Society, and Angewandte Chemie. His work bridges fundamental chemical research with practical applications in pharmaceutical development and sustainable manufacturing. As a dedicated mentor, Professor Rueping has supervised numerous graduate students and postdoctoral researchers who contribute to his diverse research portfolio. His laboratory operates state-of-the-art facilities for advanced organic synthesis, photochemistry, electrochemistry, and materials characterization. Current research directions include developing new methodologies for late-stage functionalization of pharmaceutical compounds, creating sustainable approaches to chemical manufacturing, and engineering novel catalytic materials for energy applications. His group's recent expansion into diagnostic technologies (nanobody-based lateral flow assays) demonstrates the versatility and interdisciplinary nature of his research program.

Can Dincerمشاهده پروفایل

استاد

• Bioanalytical Materials
• Sensors and Microsystems
• Data Science
• +۴ مورد دیگر

Prof. Can Dincer is a Professor of Sensors and Wearables for Healthcare at the TUM School of Computation, Information and Technology, Technische Universität München (TUM). His research focuses on bioanalytical materials, wearable sensors, and AI-driven diagnostics for One-Health applications, integrating disposable sensor technology with data science. He holds a doctorate from the University of Freiburg (summa cum laude, 2016) and worked as a visiting scientist at Imperial College London before joining TUM in 2024. He is a member of the Munich Institute of Biomedical Engineering (MIBE). Key research interests include: Development of wearable biosensors for real-time health monitoring CRISPR-based diagnostics for nucleic acids and proteins AI integration for therapeutic drug monitoring in sepsis and other critical conditions Environmental health connections via point-of-need diagnostics Notable achievements include the 2021 Biosensors & Bioelectronics Best Paper Award and inclusion in Stanford's World's Top 2% Scientists since 2022. His work spans clinical applications, microfluidic platforms, and nanotechnology-based solutions for healthcare challenges. Publications highlight innovations like optogenetic bioassays (Science Advances, 2024), CRISPR-powered multiplexed biosensors, and wearable systems for continuous biomarker monitoring. His research bridges material science, electrical engineering, and biomedicine to create practical diagnostic tools. Prof. Dincer collaborates across disciplines, focusing on translating lab innovations into clinical and commercial applications through advanced sensor technologies.

Beate Escherمشاهده پروفایل

استاد

• Environmental Toxicology
• In Vitro Bioassays
• New Approach Methods (NAMs)
• +۱۲ مورد دیگر

Prof. Dr. Beate Escher is Head of the Department of Cell Toxicology at the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, Germany. She holds professorial positions at Eberhard Karls University of Tübingen , is a Privatdozent at ETH Zurich , and is affiliated with the University of Queensland and Griffith University in Australia. Her research program focuses on advancing in vitro bioassays and New Approach Methods (NAMs) for environmental and human health risk assessment of micropollutants. Her research interests lie at the intersection of environmental toxicology , molecular toxicology , and exposure science . She develops and applies bioanalytical tools for water quality assessment, with a focus on pharmaceuticals, pesticides, and transformation products. Her work includes mechanism-based toxicity assessment , toxicokinetic-toxicodynamic (TKTD) modeling , and the development of the CITEPro robotic bioassay platform for high-throughput screening. She integrates omics data , computational modeling , and machine learning to improve chemical hazard characterization. Recent publications highlight trends in chemical mixture toxicity , safe-by-design chemicals , ionic compound assessment , and machine learning applications in toxicology. Her work increasingly leverages data-driven approaches to prioritize contaminants and predict biological effects across species. Scientific Awards: Highly Cited Researcher (Web of Science/Clarivate, Top 0.1%, 2020) Outstanding Achievements in Environmental Science and Technology (ES&T & ACS ENVR, 2023) Advising and Grants: She supervises multiple doctoral students and leads major collaborative projects such as InCeTo, MibiTox, nanoINHALE, and SafePol. She received an Australian Research Council grant (2011–2014) and leads Swiss National Science Foundation-funded initiatives. She was a member of the German Science Council (2017–2024) and serves on the Board of Reviewing Editors of SCIENCE . Labs and Teams: She leads the Cell Toxicology team at UFZ, which includes researchers such as Dr. Luise Henneberger, Dr. Julia Huchthausen, and Dr. Haotian Wang. The team operates the CITEPro platform and contributes to international consortia focused on exposome research and chemical safety.

• Proteomics
• Bioinformatics
• Cancer Diagnostics
• +۳ مورد دیگر

Young-Hee Lee is a Ph.D. candidate and Lecturer at the Technical University of Munich (TUM), affiliated with the TUM School of Engineering and Design and the Institute for Communications and Navigation. Her research focuses on proteomics, with emphasis on protein citrullination dynamics, phosphoproteomics in cancer diagnostics, and advanced mass spectrometry techniques. Her recent work includes the development of high-throughput proteomic workflows for ischemic stroke biomarker discovery and the application of deep learning to enhance citrullination identification. She contributes to methodological innovations in peptide extraction and single-cell proteomics sensitivity. Lee is part of the Chair of Communication and Navigation led by Prof. Christoph Günther, located at Theresienstraße 90, Munich. Her research bridges computational biology and biochemical analysis, with applications in cancer, neuroscience, and viral proteomics.

• Computational Chemistry
• Computer-Aided Drug Design
• Cheminformatics
• +۱۲ مورد دیگر

Andrea Volkamer is a computational chemist and active principal investigator in the field of computer-aided drug design (CADD), with a focus on kinase targets, druggability prediction, and machine learning applications. She has published extensively in journals such as the Journal of Chemical Information and Modeling and Journal of Medicinal Chemistry , with recent work up to 2025 indicating an ongoing academic research program. Her research group, referred to as 'volkamerlab,' develops open-source tools including DoGSite, KiSSim, KinFragLib, and TeachOpenCADD, which are widely used in both academic and industrial drug discovery settings. Her research interests span computational drug discovery , structural bioinformatics , kinase inhibitor design , off-target and polypharmacology prediction , and educational platforms for CADD . She emphasizes open science and reproducibility, particularly through the TeachOpenCADD initiative, which provides interactive Jupyter Notebooks and KNIME workflows for teaching cheminformatics concepts. The 15 most recent publications reflect a strong trend toward integrating machine learning and deep learning (e.g., transformers, graph neural networks) with structure-based methods such as molecular docking, free energy calculations, and binding site comparison. Her work increasingly addresses real-world challenges in drug discovery, including kinase mutation resistance, selectivity optimization, and in vivo toxicity prediction using conformal and hybrid models. Scientific Contributions and Awards: Development of key computational tools: DoGSite, KiSSim, KinFragLib, TeachOpenCADD. Leadership in open-source and open-education initiatives in cheminformatics. Active publication record in top-tier journals with interdisciplinary impact. Advising and Grants: While specific student names and grant details are not mentioned in the provided text, her role as a corresponding author on numerous publications and the existence of a dedicated research lab ('volkamerlab') imply that she mentors students and postdoctoral researchers. She likely secures competitive funding to support her research in computational drug discovery and method development. Labs and Teams: She leads the Volkamer Lab ('volkamerlab'), which focuses on developing and applying computational methods for drug discovery. The lab collaborates with both academic and pharmaceutical partners and emphasizes open-source software development and educational outreach.

Christoph Diehlمشاهده پروفایل

پژوهشگر

• Synthetic Biology
• Biocatalysis
• Metabolic Engineering
• +۶ مورد دیگر

Dr. Christoph Diehl is a researcher at the Faculty of Chemistry , affiliated with the Organic Chemistry and Biocatalysis Group at the University of Bielefeld . His work focuses on synthetic biology and biocatalysis, particularly in developing biochemical systems for CO 2 fixation and complex molecule synthesis. Current Affiliation: University of Bielefeld, Faculty of Chemistry Research Group: Organic Chemistry and Biocatalysis / Center for Biotechnology (CeBiTec) Research Interests Dr. Diehl specializes in: Designing synthetic CO 2 fixation cycles (THETA, HOPAC) Developing in vitro biochemical networks Engineering biocatalytic enzyme cascades Optimizing carbon utilization for chemical production Integrating machine learning with metabolic engineering Creating cell-free systems for biomanufacturing Publication Trends His recent work emphasizes synthetic CO 2 fixation pathways, biocatalytic cascade design, and machine learning-guided optimization of metabolic systems. He has pioneered modular approaches for terpene/polyketide synthesis from CO 2 and developed novel carboxylation modules.